Kimberly Manhard insider trades

Open-market stock purchases and sales by Kimberly Manhard, Director at Inhibrx Biosciences, Inc, from SEC Form 4 filings since Jan 28, 2010.

Recent trades

DateStockTradeValue
Sep 15, 2026INBX Inhibrx Biosciences, IncSold$52.5K
Sep 14, 2026INBX Inhibrx Biosciences, IncSold$55.1K
Sep 11, 2026INBX Inhibrx Biosciences, IncSold$55.9K
Sep 9, 2026INBX Inhibrx Biosciences, IncSold$57.9K
Sep 8, 2026INBX Inhibrx Biosciences, IncSold$57.6K
Jun 3, 2026INBX Inhibrx Biosciences, IncBought (not open market)—
Jun 3, 2026INBX Inhibrx Biosciences, IncBought (not open market)—

Companies traded

  • INBX Inhibrx Biosciences, Inc: 1 buy, 5 sales, last Sep 15, 2026
  • INXB Inhibrx Biosciences, Inc: other filings, last May 30, 2024
  • HRTX Heron Therapeutics, Inc /de/: 15 sales, last Apr 13, 2023
  • RDEA Ardea Biosciences, Inc./DE: 31 sales, last Jun 19, 2012

Get free alerts when Kimberly Manhard files a new trade →